-
1
-
-
33747607482
-
Clinical practice guidelines in oncology
-
Non-small cell lung cancer
-
Non-small cell lung cancer. Clinical practice guidelines in oncology. JNCCN 4 6 (2006) 548-582
-
(2006)
JNCCN
, vol.4
, Issue.6
, pp. 548-582
-
-
-
2
-
-
0026759013
-
New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification
-
Bulzebruck H., Bopp R., Drings P., Bauer E., Krysa S., Probst G., et al. New aspects in the staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer 70 5 (1992) 1102-1110
-
(1992)
Cancer
, vol.70
, Issue.5
, pp. 1102-1110
-
-
Bulzebruck, H.1
Bopp, R.2
Drings, P.3
Bauer, E.4
Krysa, S.5
Probst, G.6
-
3
-
-
0023922084
-
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial
-
Rapp E., Pater J.L., Willan A., Cormier Y., Murray N., Evans W.K., et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial. J Clin Oncol 6 4 (1988) 633-641
-
(1988)
J Clin Oncol
, vol.6
, Issue.4
, pp. 633-641
-
-
Rapp, E.1
Pater, J.L.2
Willan, A.3
Cormier, Y.4
Murray, N.5
Evans, W.K.6
-
4
-
-
0025735389
-
A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study
-
Weick J.K., Crowley J., Natale R.B., Hom B.L., Rivkin S., Coltman C.A., et al. A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol 9 7 (1991) 1157-1162
-
(1991)
J Clin Oncol
, vol.9
, Issue.7
, pp. 1157-1162
-
-
Weick, J.K.1
Crowley, J.2
Natale, R.B.3
Hom, B.L.4
Rivkin, S.5
Coltman, C.A.6
-
5
-
-
58049199286
-
-
Non-small Cell Lung Cancer Collaborative Group: chemotherapy for non-small cell lung cancer. The Cochrane Library, 2000, Issue 2. http://gateway.ut.ovid.com.proxy.medlib.iupui.edu/gw1/ovidweb.cgi.
-
Non-small Cell Lung Cancer Collaborative Group: chemotherapy for non-small cell lung cancer. The Cochrane Library, 2000, Issue 2. http://gateway.ut.ovid.com.proxy.medlib.iupui.edu/gw1/ovidweb.cgi.
-
-
-
-
6
-
-
0037050352
-
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
-
Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346 2 (2002) 92-98
-
(2002)
N Engl J Med
, vol.346
, Issue.2
, pp. 92-98
-
-
Schiller, J.H.1
Harrington, D.2
Belani, C.P.3
Langer, C.4
Sandler, A.5
Krook, J.6
-
7
-
-
23844515641
-
A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the alpha oncology trial (A1-99002L)
-
Treat J., Belani C.P., Edelman M.J., Socinski M.A., Ansari R.H., Obassaju C.K., et al. A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): update of the alpha oncology trial (A1-99002L). J Clin Oncol 23 16S (2005) 7025
-
(2005)
J Clin Oncol
, vol.23
, Issue.16 S
, pp. 7025
-
-
Treat, J.1
Belani, C.P.2
Edelman, M.J.3
Socinski, M.A.4
Ansari, R.H.5
Obassaju, C.K.6
-
8
-
-
4344670233
-
Population variation in the initial treatment of non-small-cell lung cancer
-
Potosky A.L., Saxman S., Wallace R.B., and Lynch C.F. Population variation in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22 16 (2004) 3261-3268
-
(2004)
J Clin Oncol
, vol.22
, Issue.16
, pp. 3261-3268
-
-
Potosky, A.L.1
Saxman, S.2
Wallace, R.B.3
Lynch, C.F.4
-
9
-
-
14644396447
-
Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from Surveillance, Epidemiology and End Results-Medicare
-
Ramsey S.D., Howlader N., Etzioni R.D., and Donato B. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from Surveillance, Epidemiology and End Results-Medicare. J Clin Oncol 22 24 (2004) 4971-4978
-
(2004)
J Clin Oncol
, vol.22
, Issue.24
, pp. 4971-4978
-
-
Ramsey, S.D.1
Howlader, N.2
Etzioni, R.D.3
Donato, B.4
-
10
-
-
0034085866
-
Who gets chemotherapy for metastatic lung cancer?
-
Earle C.C., Venditti L.N., Neumann P.J., Gelber R.D., Weinstein M.C., Potosky A.L., et al. Who gets chemotherapy for metastatic lung cancer?. Chest 117 (2000) 1239-1246
-
(2000)
Chest
, vol.117
, pp. 1239-1246
-
-
Earle, C.C.1
Venditti, L.N.2
Neumann, P.J.3
Gelber, R.D.4
Weinstein, M.C.5
Potosky, A.L.6
-
11
-
-
0032212492
-
A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort
-
Hillner B.E., McDonald M.K., Desch C.E., Smith T.H., Penberthy L.T., Rechin S.M., et al. A comparison of patterns of care of nonsmall cell lung carcinoma patients in a younger and Medigap commercially insured cohort. Cancer 83 (1998) 1930-1937
-
(1998)
Cancer
, vol.83
, pp. 1930-1937
-
-
Hillner, B.E.1
McDonald, M.K.2
Desch, C.E.3
Smith, T.H.4
Penberthy, L.T.5
Rechin, S.M.6
-
12
-
-
58049205307
-
-
U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Drugs@FDA. FDA approved drug products. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Search_Drug_Name [accessed 17.05.07].
-
U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Drugs@FDA. FDA approved drug products. Available at http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.Search_Drug_Name [accessed 17.05.07].
-
-
-
-
13
-
-
58049216966
-
-
National Cancer Institute (NCI): SEER-Medicare Publications, 2005. http://healthservices.cancer.gov/seermedicare/overview/publications.html.
-
National Cancer Institute (NCI): SEER-Medicare Publications, 2005. http://healthservices.cancer.gov/seermedicare/overview/publications.html.
-
-
-
-
14
-
-
33845961014
-
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies.
-
Shih T., and Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 28 11 (2006) 1779-1802
-
(2006)
Clin Ther
, vol.28
, Issue.11
, pp. 1779-1802
-
-
Shih, T.1
Lindley, C.2
-
15
-
-
33646676706
-
Antiangiogenic drugs in non-small cell lung cancer treatment
-
Cascone T., Troiani T., Morelli M.P., Gridelli C., and Ciardiello F. Antiangiogenic drugs in non-small cell lung cancer treatment. Curr Opin Oncol 18 2 (2006) 151-155
-
(2006)
Curr Opin Oncol
, vol.18
, Issue.2
, pp. 151-155
-
-
Cascone, T.1
Troiani, T.2
Morelli, M.P.3
Gridelli, C.4
Ciardiello, F.5
-
16
-
-
28044438900
-
How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care
-
Kris M.G. How today's developments in the treatment of non-small cell lung cancer will change tomorrow's standards of care. Oncologist 10 Suppl. 2 (2005) 23-29
-
(2005)
Oncologist
, vol.10
, Issue.SUPPL. 2
, pp. 23-29
-
-
Kris, M.G.1
-
17
-
-
7144229342
-
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study
-
Georgoulias V., Androulakis N., Dimopoulos A.M., Kourousis C., Kakolyris S., Papadakis E., et al. First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study. Ann Oncol 9 3 (1998) 331-334
-
(1998)
Ann Oncol
, vol.9
, Issue.3
, pp. 331-334
-
-
Georgoulias, V.1
Androulakis, N.2
Dimopoulos, A.M.3
Kourousis, C.4
Kakolyris, S.5
Papadakis, E.6
-
18
-
-
33745632406
-
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
-
Booton R., Lorigan P., Anderson H., Baka S., Ashcroft L., Nicolson M., et al. A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group (BTOG1). Ann Oncol 17 7 (2006) 1111-1119
-
(2006)
Ann Oncol
, vol.17
, Issue.7
, pp. 1111-1119
-
-
Booton, R.1
Lorigan, P.2
Anderson, H.3
Baka, S.4
Ashcroft, L.5
Nicolson, M.6
-
19
-
-
0036810227
-
Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial
-
Rosell R., Gatzemeier U., Betticher D.C., Keppler U., Macha H.N., Pirker R., et al. Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Ann Oncol 13 10 (2002) 1539-1549
-
(2002)
Ann Oncol
, vol.13
, Issue.10
, pp. 1539-1549
-
-
Rosell, R.1
Gatzemeier, U.2
Betticher, D.C.3
Keppler, U.4
Macha, H.N.5
Pirker, R.6
-
20
-
-
0346560025
-
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975
-
Smit E.F., van Meerbeeck J.P., Lianes P., Debruyne C., Legrand C., Schramel F., et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 21 21 (2003) 3909-3917
-
(2003)
J Clin Oncol
, vol.21
, Issue.21
, pp. 3909-3917
-
-
Smit, E.F.1
van Meerbeeck, J.P.2
Lianes, P.3
Debruyne, C.4
Legrand, C.5
Schramel, F.6
-
21
-
-
17344384668
-
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
-
Sandler A.B., Nemunaitis J., Denham C., von Pawel J., Cormier Y., Gazemeier U., et al. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18 1 (2000) 122-130
-
(2000)
J Clin Oncol
, vol.18
, Issue.1
, pp. 122-130
-
-
Sandler, A.B.1
Nemunaitis, J.2
Denham, C.3
von Pawel, J.4
Cormier, Y.5
Gazemeier, U.6
-
22
-
-
0042661285
-
Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in Stage IIIb and IV non-small cell lung cancer: a phase III randomized trial
-
Zatloukal P., Petruzelka L., Zemanova M., Kolek V., Skrickova J., Pesek M., et al. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in Stage IIIb and IV non-small cell lung cancer: a phase III randomized trial. Lung Cancer 41 3 (2003) 321-331
-
(2003)
Lung Cancer
, vol.41
, Issue.3
, pp. 321-331
-
-
Zatloukal, P.1
Petruzelka, L.2
Zemanova, M.3
Kolek, V.4
Skrickova, J.5
Pesek, M.6
|